Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)

[1]  Kenneth E Rosenzweig,et al.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) , 2013, Radiation Oncology.

[2]  Joe Y. Chang,et al.  Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[3]  B. Loo,et al.  Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  J. Luketich,et al.  Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. , 2012, The Journal of thoracic and cardiovascular surgery.

[5]  Benjamin Movsas,et al.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. , 2011, Journal of the National Cancer Institute.

[6]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. , 2010, International journal of radiation oncology, biology, physics.

[7]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[8]  Lech Papiez,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.

[9]  P. Balter,et al.  Stereotactic Body Radiation Therapy Results in Promising Local Control in Patients with Recurrent or Secondary Lung Parenchyma Cancer after Definitive Conventional Thoracic Radiotherapy , 2009 .

[10]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Kenneth E Rosenzweig,et al.  Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? , 2008, International journal of radiation oncology, biology, physics.

[13]  Masahiro Hiraoka,et al.  Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.

[14]  G. Grabenbauer,et al.  Hypofractionated Stereotactic Radiotherapy for Primary and Secondary Intrapulmonary Tumors , 2006, Strahlentherapie und Onkologie.

[15]  Quynh-Thu Le,et al.  Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[17]  T. Tada,et al.  Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy , 2005, International Journal of Clinical Oncology.

[18]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[19]  G. Jiang,et al.  Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. , 2003, International journal of radiation oncology, biology, physics.

[20]  T. Nakajima,et al.  Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[21]  J. Wong,et al.  Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.

[22]  S. Tyldesley,et al.  Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. , 2001, International journal of radiation oncology, biology, physics.

[23]  B. Jeremic,et al.  Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Spirou,et al.  Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations. , 1994, Medical physics.

[25]  A. Manatunga,et al.  The Reirradiation of Recurrent Bronchogenic Carcinoma with External Beam Irradiation , 1993, American journal of clinical oncology.

[26]  R Mohan,et al.  A comprehensive three-dimensional radiation treatment planning system. , 1988, International journal of radiation oncology, biology, physics.

[27]  R. Melbye,et al.  Lung cancer: Retreatment of local recurrence after definitive irradiation , 1982, Cancer.

[28]  M. Melamed,et al.  Multiple primary lung cancers. , 1975, The Journal of thoracic and cardiovascular surgery.

[29]  M E Burt,et al.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.